Cargando…
Whole Exome Sequencing in the Male Breast Cancer with Prolactinoma: A Case Report and Literature Review
Male breast cancer (MBC) is rare and accounts for approximately 1% of all breast cancer cases worldwide. Previous studies have suggested that several factors significantly increase the risk of MBC. Prolactinoma has the highest incidence rate among patients with functional pituitary tumors. However,...
Autores principales: | Hao, Shuai, Huang, Miao, Tian, Wuguo, Chen, Yi, Zhao, Jianjie, Luo, Donglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779730/ https://www.ncbi.nlm.nih.gov/pubmed/33408891 http://dx.doi.org/10.4048/jbc.2020.23.e63 |
Ejemplares similares
-
Analysis and prediction model of ferroptosis related genes in breast cancer
por: Wang, Lingli, et al.
Publicado: (2022) -
Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence
por: Hao, Shuai, et al.
Publicado: (2020) -
Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression
por: Tian, Wuguo, et al.
Publicado: (2018) -
Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials
por: Hao, Shuai, et al.
Publicado: (2017) -
Whole-exome sequencing of rectal neuroendocrine tumors
por: Li, Yuanliang, et al.
Publicado: (2023)